Terri B Sebree - Net Worth and Insider Trading

Terri B Sebree Net Worth

The estimated net worth of Terri B Sebree is at least $775,113 dollars as of 2024-05-12. Terri B Sebree is the President of Zynerba Pharmaceuticals Inc and owns about 596,241 shares of Zynerba Pharmaceuticals Inc (ZYNE) stock worth over $775,113. Details can be seen in Terri B Sebree's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Terri B Sebree has not made any transactions after 2023-09-13 and currently still holds the listed stock(s).

Transaction Summary of Terri B Sebree

To

Terri B Sebree Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Terri B Sebree owns 1 companies in total, including Zynerba Pharmaceuticals Inc (ZYNE) .

Click here to see the complete history of Terri B Sebree’s form 4 insider trades.

Insider Ownership Summary of Terri B Sebree

Ticker Comapny Transaction Date Type of Owner
ZYNE Zynerba Pharmaceuticals Inc 2023-09-13 President

Terri B Sebree Latest Holdings Summary

Terri B Sebree currently owns a total of 1 stock. Terri B Sebree owns 596,241 shares of Zynerba Pharmaceuticals Inc (ZYNE) as of September 13, 2023, with a value of $775,113.

Latest Holdings of Terri B Sebree

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ZYNE Zynerba Pharmaceuticals Inc 2023-09-13 596,241 1.30 775,113

Holding Weightings of Terri B Sebree


Terri B Sebree Form 4 Trading Tracker

According to the SEC Form 4 filings, Terri B Sebree has made a total of 3 transactions in Zynerba Pharmaceuticals Inc (ZYNE) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Zynerba Pharmaceuticals Inc is the sale of 12,401 shares on September 13, 2023, which brought Terri B Sebree around $16,493.

Insider Trading History of Terri B Sebree

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Terri B Sebree Trading Performance

GuruFocus tracks the stock performance after each of Terri B Sebree's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Terri B Sebree is -5.38%. GuruFocus also compares Terri B Sebree's trading performance to market benchmark return within the same time period. The performance of stocks bought by Terri B Sebree within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Terri B Sebree's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Terri B Sebree

Average Return

Average return per transaction

Outperforming Transactions

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 20.07
Relative Return to S&P 500(%) 19.1

Terri B Sebree Ownership Network

Ownership Network List of Terri B Sebree

No Data

Ownership Network Relation of Terri B Sebree


Terri B Sebree Owned Company Details

What does Zynerba Pharmaceuticals Inc do?

Who are the key executives at Zynerba Pharmaceuticals Inc?

Terri B Sebree is the President of Zynerba Pharmaceuticals Inc. Other key executives at Zynerba Pharmaceuticals Inc include Chief Financial Officer James E Fickenscher , director & Chairman & Chief Exec. Officer Armando Anido , and VP & Commercial & Business Dev. Brian Rosenberger .

Zynerba Pharmaceuticals Inc (ZYNE) Insider Trades Summary

Over the past 18 months, Terri B Sebree made 2 insider transaction in Zynerba Pharmaceuticals Inc (ZYNE) with a net sale of 37,062. Other recent insider transactions involving Zynerba Pharmaceuticals Inc (ZYNE) include a net sale of 53,283 shares made by Armando Anido , a net sale of 26,767 shares made by James E Fickenscher , and a net sale of 19,074 shares made by Brian Rosenberger .

In summary, during the past 3 months, insiders sold 0 shares of Zynerba Pharmaceuticals Inc (ZYNE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 139,381 shares of Zynerba Pharmaceuticals Inc (ZYNE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 139,381 shares.

Zynerba Pharmaceuticals Inc (ZYNE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Zynerba Pharmaceuticals Inc Insider Transactions

No Available Data

Terri B Sebree Mailing Address

Above is the net worth, insider trading, and ownership report for Terri B Sebree. You might contact Terri B Sebree via mailing address: Zynerba Pharmaceuticals, Inc., 80 W. Lancaster Avenue, Suite 300, Devon Pa 19333.

Discussions on Terri B Sebree

No discussions yet.